196 related articles for article (PubMed ID: 38321204)
1. SHP-1 inhibition targets leukaemia stem cells to restore immunosurveillance and enhance chemosensitivity by metabolic reprogramming.
Xu X; Yu Y; Zhang W; Ma W; He C; Qiu G; Wang X; Liu Q; Zhao M; Xie J; Tao F; Perry JM; Liu Q; Rao S; Kang X; Zhao M; Jiang L
Nat Cell Biol; 2024 Mar; 26(3):464-477. PubMed ID: 38321204
[TBL] [Abstract][Full Text] [Related]
2. Overcoming Wnt-β-catenin dependent anticancer therapy resistance in leukaemia stem cells.
Perry JM; Tao F; Roy A; Lin T; He XC; Chen S; Lu X; Nemechek J; Ruan L; Yu X; Dukes D; Moran A; Pace J; Schroeder K; Zhao M; Venkatraman A; Qian P; Li Z; Hembree M; Paulson A; He Z; Xu D; Tran TH; Deshmukh P; Nguyen CT; Kasi RM; Ryan R; Broward M; Ding S; Guest E; August K; Gamis AS; Godwin A; Sittampalam GS; Weir SJ; Li L
Nat Cell Biol; 2020 Jun; 22(6):689-700. PubMed ID: 32313104
[TBL] [Abstract][Full Text] [Related]
3. Phosphofructokinase 1 platelet isoform induces PD-L1 expression to promote glioblastoma immune evasion.
Wang S; Park SH; Lim JS; Park YY; Du L; Lee JH
Genes Genomics; 2022 Dec; 44(12):1509-1517. PubMed ID: 35917090
[TBL] [Abstract][Full Text] [Related]
4. Overcoming BCR::ABL1 dependent and independent survival mechanisms in chronic myeloid leukaemia using a multi-kinase targeting approach.
Busch C; Mulholland T; Zagnoni M; Dalby M; Berry C; Wheadon H
Cell Commun Signal; 2023 Nov; 21(1):342. PubMed ID: 38031192
[TBL] [Abstract][Full Text] [Related]
5. Arsenic trioxide synergistically promotes the antileukaemic activity of venetoclax by downregulating Mcl-1 in acute myeloid leukaemia cells.
Cho H; Jang JE; Eom JI; Jeung HK; Chung H; Kim JS; Cheong JW; Min YH
Exp Hematol Oncol; 2021 Apr; 10(1):28. PubMed ID: 33858507
[TBL] [Abstract][Full Text] [Related]
6. Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion.
Paczulla AM; Rothfelder K; Raffel S; Konantz M; Steinbacher J; Wang H; Tandler C; Mbarga M; Schaefer T; Falcone M; Nievergall E; Dörfel D; Hanns P; Passweg JR; Lutz C; Schwaller J; Zeiser R; Blazar BR; Caligiuri MA; Dirnhofer S; Lundberg P; Kanz L; Quintanilla-Martinez L; Steinle A; Trumpp A; Salih HR; Lengerke C
Nature; 2019 Aug; 572(7768):254-259. PubMed ID: 31316209
[TBL] [Abstract][Full Text] [Related]
7. Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis.
Lee JH; Liu R; Li J; Zhang C; Wang Y; Cai Q; Qian X; Xia Y; Zheng Y; Piao Y; Chen Q; de Groot JF; Jiang T; Lu Z
Nat Commun; 2017 Oct; 8(1):949. PubMed ID: 29038421
[TBL] [Abstract][Full Text] [Related]
8. Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine.
Buettner R; Nguyen LXT; Morales C; Chen MH; Wu X; Chen LS; Hoang DH; Hernandez Vargas S; Pullarkat V; Gandhi V; Marcucci G; Rosen ST
J Hematol Oncol; 2021 Apr; 14(1):70. PubMed ID: 33902674
[TBL] [Abstract][Full Text] [Related]
9. HOTAIRM1 knockdown enhances cytarabine-induced cytotoxicity by suppression of glycolysis through the Wnt/β-catenin/PFKP pathway in acute myeloid leukemia cells.
Chen L; Hu N; Wang C; Zhao H
Arch Biochem Biophys; 2020 Feb; 680():108244. PubMed ID: 31904363
[TBL] [Abstract][Full Text] [Related]
10. Preclinical Evaluation of the Multiple Tyrosine Kinases Inhibitor Anlotinib in Leukemia Stem Cells.
Jiang Y; Liu L; Jiang Y; Li Z; Feng L; Zhuang X; Lin Z; Chen Q; Chen G; He J; Li G; Zha J; Xu B
Pharmaceuticals (Basel); 2022 Oct; 15(11):. PubMed ID: 36355485
[TBL] [Abstract][Full Text] [Related]
11. SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism.
Polak A; Bialopiotrowicz E; Krzymieniewska B; Wozniak J; Stojak M; Cybulska M; Kaniuga E; Mikula M; Jablonska E; Gorniak P; Noyszewska-Kania M; Szydlowski M; Piechna K; Piwocka K; Bugajski L; Lech-Maranda E; Barankiewicz J; Kolkowska-Lesniak A; Patkowska E; Glodkowska-Mrowka E; Baran N; Juszczynski P
Cell Death Dis; 2020 Nov; 11(11):956. PubMed ID: 33159047
[TBL] [Abstract][Full Text] [Related]
12. HCK maintains the self-renewal of leukaemia stem cells via CDK6 in AML.
Li Z; Wang F; Tian X; Long J; Ling B; Zhang W; Xu J; Liang A
J Exp Clin Cancer Res; 2021 Jun; 40(1):210. PubMed ID: 34167558
[TBL] [Abstract][Full Text] [Related]
13. Quiescence regulation by normal haematopoietic stem cells and leukaemia stem cells.
Gudmundsson KO; Du Y
FEBS J; 2023 Aug; 290(15):3708-3722. PubMed ID: 35514133
[TBL] [Abstract][Full Text] [Related]
14. Targeting Acute Myeloid Leukemia Stem Cells Through Perturbation of Mitochondrial Calcium.
Sheth AI; Althoff MJ; Tolison H; Engel K; Amaya ML; Krug AE; Young TN; Minhajuddin M; Pei S; Patel SB; Winters A; Miller R; Shelton IT; St-Germain J; Ling T; Jones CL; Raught B; Gillen AE; Ransom M; Staggs S; Smith CA; Pollyea DA; Stevens BM; Jordan CT
Cancer Discov; 2024 May; ():. PubMed ID: 38787341
[TBL] [Abstract][Full Text] [Related]
15. Hypoxic exposure activates the B cell-specific Moloney murine leukaemia virus integration site 1/PI3K/Akt axis and promotes EMT in leukaemia stem cells.
Jiang M; He G; Li J; Li J; Guo X; Gao J
Oncol Lett; 2021 Feb; 21(2):98. PubMed ID: 33376531
[TBL] [Abstract][Full Text] [Related]
16. Phosphofructokinase 1 Platelet Isoform Promotes β-Catenin Transactivation for Tumor Development.
Lee JH; Shao F; Ling J; Lu S; Liu R; Du L; Chung JW; Koh SS; Leem SH; Shao J; Xing D; An Z; Lu Z
Front Oncol; 2020; 10():211. PubMed ID: 32195176
[TBL] [Abstract][Full Text] [Related]
17. Cardiac glycoside ouabain efficiently targets leukemic stem cell apoptotic machinery independent of cell differentiation status.
Poohadsuan J; O'Doherty GA; Owattanapanich W; Kungwankiattichai S; Rojanasakul Y; Issaragrisil S; Luanpitpong S
Cell Commun Signal; 2023 Oct; 21(1):283. PubMed ID: 37828578
[TBL] [Abstract][Full Text] [Related]
18. PI3Kγ maintains the self-renewal of acute myeloid leukemia stem cells by regulating the pentose phosphate pathway.
Gu H; Chen C; Hou ZS; He XD; Xie S; Ni J; Qian C; Cheng X; Jiang T; Yang C; Roberts TM; Zheng J; Varner JA; Armstrong SA; Zhao JJ
Blood; 2024 May; 143(19):1965-1979. PubMed ID: 38271660
[TBL] [Abstract][Full Text] [Related]
19. Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity.
Rodriguez-Zabala M; Ramakrishnan R; Reinbach K; Ghosh S; Oburoglu L; Falqués-Costa A; Bellamkonda K; Ehinger M; Peña-Martínez P; Puente-Moncada N; Lilljebjörn H; Cammenga J; Pronk CJ; Lazarevic V; Fioretos T; Hagström-Andersson AK; Woods NB; Järås M
Blood Adv; 2023 Sep; 7(18):5382-5395. PubMed ID: 37505194
[TBL] [Abstract][Full Text] [Related]
20. LncRNA MAGI2-AS3 inhibits the self-renewal of leukaemic stem cells by promoting TET2-dependent DNA demethylation of the LRIG1 promoter in acute myeloid leukaemia.
Chen L; Fan X; Zhu J; Chen X; Liu Y; Zhou H
RNA Biol; 2020 Jun; 17(6):784-793. PubMed ID: 32174258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
